S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
Slow start to New York's legal pot market leaves farmers holding the bag
“Amazon Loophole” could hand you $28,544 in “royalty” payouts (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
Slow start to New York's legal pot market leaves farmers holding the bag
“Amazon Loophole” could hand you $28,544 in “royalty” payouts (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
Slow start to New York's legal pot market leaves farmers holding the bag
“Amazon Loophole” could hand you $28,544 in “royalty” payouts (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
Slow start to New York's legal pot market leaves farmers holding the bag
“Amazon Loophole” could hand you $28,544 in “royalty” payouts (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
LON:DEST

Destiny Pharma (DEST) Share Forecast, Price & News

GBX 29.80
0.00 (0.00%)
(As of 06/2/2023 ET)
Compare
Today's Range
29.62
30
50-Day Range
28
36
52-Week Range
27
61.85
Volume
188,723 shs
Average Volume
376,087 shs
Market Capitalization
£28.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

DEST stock logo

About Destiny Pharma (LON:DEST) Stock

Destiny Pharma plc, a biotechnology company, focuses on the discovery, development, and commercialization of medicines for the treatment of infectious diseases in the United Kingdom. The company is involved in developing NTCD-M3 that is in Phase III clinical trial for the prevention of recurrent Clostridioides diffcile infections; XF-73 Nasal, which is in Phase II clinical trial for the prevention of post-surgical staphylococcal infection; and XF-73 Dermal that is in Phase I clinical trial for the treatment of skin infections of antibiotic resistant bacteria. It also develops SPOR-COV, biotherapeutic product, which is in preclinical stage for the prevention of COVID-19 and other viral respiratory infections; and XF Drugs Biofilm that is in preclinical stage for the treatment of antibiotic resistant biofilm and bacterial aggregate associated infections. In addition, the company is involved in the development of XF drugs for the treatment of respiratory, oral mucosa, and ocular infection diseases. Destiny Pharma plc has collaboration agreements with China Medical System Holdings Limited; SporeGen Limited; the University of Southampton; Aston University; the University of Sheffield; and Cardiff University and Tianjin Medical University. The company was incorporated in 1996 and is based in Brighton, the United Kingdom.

Receive DEST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Destiny Pharma and its competitors with MarketBeat's FREE daily newsletter.

DEST Stock News Headlines

“Amazon Loophole” could hand you $28,544 in “royalty” payouts
Thanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.
Destiny Pharma chief steps down
“Amazon Loophole” could hand you $28,544 in “royalty” payouts
Thanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.
Destiny Pharma focused on delivering further deals
Destiny Pharma broker upbeat on latest data for key asset
Destiny Pharma nasal gel results showcased in leading journal
Destiny Pharma "making real progress"
Burns Treatment Market Share Likely to Grow At a CAGR
Destiny's child
See More Headlines

DEST Price History

DEST Company Calendar

Last Earnings
9/17/2020
Today
6/03/2023

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

Net Income
£-6,500,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£135,028.00
Cash Flow
GBX 11.08 per share
Book Value
GBX 10 per share

Miscellaneous

Free Float
N/A
Market Cap
£28.39 million
Optionable
Optionable
Beta
0.36

Key Executives

  • Mr. Neil Robert Clark (Age 60)
    CEO & Director
    Comp: $303k
  • Dr. William Guy Love (Age 60)
    Founder, Chief Scientific Officer & Director
    Comp: $252k
  • Mr. Shaun Claydon ACA (Age 55)
    CFO, Company Sec. & Director
    Comp: $271k
  • Dr. Stephanie Bewick
    Chief Bus. Officer
  • Dr. Yuri Martina M.B.A.
    M.D., Chief Medical Officer













DEST Stock - Frequently Asked Questions

How have DEST shares performed in 2023?

Destiny Pharma's stock was trading at GBX 53.50 at the beginning of the year. Since then, DEST stock has decreased by 44.3% and is now trading at GBX 29.80.
View the best growth stocks for 2023 here
.

How were Destiny Pharma's earnings last quarter?

Destiny Pharma plc (LON:DEST) posted its earnings results on Thursday, September, 17th. The company reported ($5.50) earnings per share (EPS) for the quarter.

What other stocks do shareholders of Destiny Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Destiny Pharma investors own include Dynavax Technologies (DVAX), AFPO.L (AFPO), Aldeyra Therapeutics (ALDX), Ares Capital (ARCC), BioCryst Pharmaceuticals (BCRX), BioNTech (BNTX), Centamin (CEY), Countryside Partnerships (CSP), Enbridge (ENB) and EQTEC (EQT).

What is Destiny Pharma's stock symbol?

Destiny Pharma trades on the London Stock Exchange (LON) under the ticker symbol "DEST."

How do I buy shares of Destiny Pharma?

Shares of DEST stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Destiny Pharma's stock price today?

One share of DEST stock can currently be purchased for approximately GBX 29.80.

How much money does Destiny Pharma make?

Destiny Pharma (LON:DEST) has a market capitalization of £28.39 million and generates £135,028.00 in revenue each year. The company earns £-6,500,000.00 in net income (profit) each year or GBX (0.09) on an earnings per share basis.

How can I contact Destiny Pharma?

Destiny Pharma's mailing address is Sussex Innovation Centre Science Park Square, Falmer, BRIGHTON, BN1 9SB, United Kingdom. The official website for the company is www.destinypharma.com. The company can be reached via phone at +44-1273-704440.

This page (LON:DEST) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -